Article ; Online: Orbital myositis in systemic lupus erythematosus: a case-based review.
2022 Volume 42, Issue 8, Page(s) 1453–1460
Abstract: Ocular complications occur in up to one-third of patients with systemic lupus erythematosus (SLE). Among them, orbital myositis (OM) is considered a rare manifestation that affects the extraocular muscles and causes pain and restriction with eye movement. ...
| Abstract | Ocular complications occur in up to one-third of patients with systemic lupus erythematosus (SLE). Among them, orbital myositis (OM) is considered a rare manifestation that affects the extraocular muscles and causes pain and restriction with eye movement. We report a case of OM in a 48-year-old female with SLE and secondary Sjogren's Syndrome, who presented headache, periorbital edema, and painful ocular movements in both eyes, with no other systemic manifestations. An orbital magnetic resonance image revealed thickening of the right medial rectus and left lateral rectus muscles. Laboratory tests were normal and there was no further disease activity. The patient was treated with prednisone 1 mg/Kg/day with a resolution of symptoms. We found 13 additional cases of OM from our literature review (11 SLE patients and 2 with discoid lupus erythematosus). There was a female predominance in these cases with a mean age of 43.6 years (SD ± 16.9). Their main clinical features included eye pain, swelling, proptosis, diplopia, and limitations in extraocular muscles, while in most of them, there was no other active systemic manifestation. Treatment with steroids led to the complete resolution of symptoms in most of these patients. The available evidence suggests that it is essential to have a high index of suspicion for OM in SLE patients even when there is no systemic disease activity so that proper treatment is initiated early. |
|---|---|
| MeSH term(s) | Adult ; Female ; Humans ; Lupus Erythematosus, Discoid/complications ; Lupus Erythematosus, Systemic/complications ; Lupus Erythematosus, Systemic/diagnosis ; Lupus Erythematosus, Systemic/drug therapy ; Male ; Middle Aged ; Myositis/diagnostic imaging ; Myositis/drug therapy ; Myositis/etiology ; Orbital Myositis/diagnostic imaging ; Orbital Myositis/drug therapy ; Orbital Myositis/etiology ; Prednisone ; Sjogren's Syndrome/complications |
| Chemical Substances | Prednisone (VB0R961HZT) |
| Language | English |
| Publishing date | 2022-04-19 |
| Publishing country | Germany |
| Document type | Case Reports ; Journal Article ; Review |
| ZDB-ID | 8286-7 |
| ISSN | 1437-160X ; 0172-8172 |
| ISSN (online) | 1437-160X |
| ISSN | 0172-8172 |
| DOI | 10.1007/s00296-022-05114-3 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 1639: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.